Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

High‐resolution definition of humoral immune response correlates of effective immunity against HIV
Galit Alter, Karen G. Dowell, Eric P. Brown, et al.
Molecular Systems Biology (2018) Vol. 14, Iss. 3
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Antibody‐mediated complement activation in pathology and protection
Benjamin S. Goldberg, Margaret E. Ackerman
Immunology and Cell Biology (2020) Vol. 98, Iss. 4, pp. 305-317
Open Access | Times Cited: 81
Hinge length contributes to the phagocytic activity of HIV-specific IgG1 and IgG3 antibodies
Thach H. Chu, Andrew R. Crowley, Iara M. Backes, et al.
PLoS Pathogens (2020) Vol. 16, Iss. 2, pp. e1008083-e1008083
Open Access | Times Cited: 68
The antibody repertoire of autoimmune sensory neuronopathies targets pathways of the innate and adaptative immune system. An autoantigenomic approach.
Christian P. Moritz, Yannick Tholance, Nadia Boutahar, et al.
Journal of Translational Autoimmunity (2025), pp. 100277-100277
Open Access
A Sample-Sparing Multiplexed ADCP Assay
Audrey L. Butler, Jonathan K. Fallon, Galit Alter
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 51
Autoantigenomics: Holistic characterization of autoantigen repertoires for a better understanding of autoimmune diseases
Christian P. Moritz, Stéphane Paul, Oda Stoevesandt, et al.
Autoimmunity Reviews (2019) Vol. 19, Iss. 2, pp. 102450-102450
Open Access | Times Cited: 38
SARS-CoV-2 antibody signatures robustly predict diverse antiviral functions relevant for convalescent plasma therapy
Harini Natarajan, Andrew R. Crowley, Savannah E. Butler, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 32
Afucosylation of HLA-specific IgG1 as a potential predictor of antibody pathogenicity in kidney transplantation
Pranay Bharadwaj, Sweta Shrestha, Tamás Pongrácz, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 11, pp. 100818-100818
Open Access | Times Cited: 21
Transient viral exposure drives functionally-coordinated humoral immune responses in HIV-1 post-treatment controllers
Luis M. Molinos‐Albert, Valérie Lorin, Valérie Monceaux, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 18
Vaccine-induced V1V2-specific antibodies control and or protect against infection with HIV, SIV and SHIV
Susan Zolla‐Pazner, Raymond A Alvarez, Xiang‐Peng Kong, et al.
Current Opinion in HIV and AIDS (2019) Vol. 14, Iss. 4, pp. 309-317
Open Access | Times Cited: 34
Streptococcus pyogenes evades adaptive immunity through specific IgG glycan hydrolysis
Andreas Naegeli, Eleni Bratanis, Christofer Karlsson, et al.
The Journal of Experimental Medicine (2019) Vol. 216, Iss. 7, pp. 1615-1629
Open Access | Times Cited: 34
Moving toward Tuberculosis Elimination. Critical Issues for Research in Diagnostics and Therapeutics for Tuberculosis Infection
Salmaan Keshavjee, Farhana Amanullah, Adithya Cattamanchi, et al.
American Journal of Respiratory and Critical Care Medicine (2018) Vol. 199, Iss. 5, pp. 564-571
Open Access | Times Cited: 28
Tensor‐structured decomposition improves systems serology analysis
Zhixin Cyrillus Tan, Madeleine C Murphy, Hakan S Alpay, et al.
Molecular Systems Biology (2021) Vol. 17, Iss. 9
Open Access | Times Cited: 22
Mining for humoral correlates of HIV control and latent reservoir size
Jishnu Das, Anush Devadhasan, Caitlyn Linde, et al.
PLoS Pathogens (2020) Vol. 16, Iss. 10, pp. e1008868-e1008868
Open Access | Times Cited: 21
The host glycomic response to pathogens
Rui Qin, Lara K. Mahal
Current Opinion in Structural Biology (2021) Vol. 68, pp. 149-156
Closed Access | Times Cited: 19
Polyfunctional antibodies: a path towards precision vaccines for vulnerable populations
Ruth A Purcell, Robert M. Theisen, Kelly B. Arnold, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Vaccinal effect of HIV-1 antibody therapy
Mar Naranjo‐Gómez, Mireia Pelegrín
Current Opinion in HIV and AIDS (2019) Vol. 14, Iss. 4, pp. 325-333
Open Access | Times Cited: 18
CIDP Antibodies Target Junction Proteins and Identify Patient Subgroups
Christian P. Moritz, Yannick Tholance, Oda Stoevesandt, et al.
Neurology Neuroimmunology & Neuroinflammation (2021) Vol. 8, Iss. 2
Open Access | Times Cited: 15
Elite and posttreatment controllers, two facets of HIV control
Andrea Mastrángelo, Riddhima Banga, Matthieu Perreau
Current Opinion in HIV and AIDS (2022) Vol. 17, Iss. 5, pp. 325-332
Open Access | Times Cited: 10
Lessons for general vaccinology research from attempts to develop an HIV vaccine
Stuart Z. Shapiro
Vaccine (2019) Vol. 37, Iss. 26, pp. 3400-3408
Closed Access | Times Cited: 16
Humoral immunity in HIV-1 post-treatment controllers
Hugo Mouquet
Current Opinion in HIV and AIDS (2024) Vol. 20, Iss. 1, pp. 80-85
Closed Access | Times Cited: 1
A role for antibodies in natural HIV control
Arnaud Moris, Mathias Pereira, Lisa A. Chakrabarti
Current Opinion in HIV and AIDS (2019) Vol. 14, Iss. 4, pp. 265-272
Open Access | Times Cited: 14
Antibody attributes that predict the neutralization and effector function of polyclonal responses to SARS-CoV-2
Harini Natarajan, Shiwei Xu, Andrew R. Crowley, et al.
BMC Immunology (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 8
Systems serology for decoding infection and vaccine-induced antibody responses to HIV-1
Srivamshi Pittala, Kyle S. Morrison, Margaret E. Ackerman
Current Opinion in HIV and AIDS (2019) Vol. 14, Iss. 4, pp. 253-264
Open Access | Times Cited: 12
Diverse antiviral IgG effector activities are predicted by unique biophysical antibody features
Hao Cheng, Karen G. Dowell, Chris Bailey‐Kellogg, et al.
Retrovirology (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top